- Conditions
- Hydrocephalus, Nervous System Diseases, Infant, Newborn Diseases
- Interventions
- Not listed
- Lead sponsor
- Transonic Systems Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Syracuse, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–10
of 10
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Hydrocephalus in Infants, Hydrocephalus Acquired
- Interventions
- Sulfur Hexafluoride Lipid Type A Microspheres 25 mg Injection Powder for Suspension [LUMASON]
- Drug
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 1 Minute to 18 Months
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Infant Development, Infant,Premature, Hydrocephalus, Neonatal Encephalopathy, Infarction, PVL, Thrombosis, Intraventricular Hemorrhage
- Interventions
- pacifier-activated device
- Device
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Eligibility
- 32 Weeks to 12 Months
- Enrollment
- 130 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2021
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Post-hemorrhagic Hydrocephalus (PHH)
- Interventions
- fCTOT cap, NIRF planar imaging, ICG
- Device · Drug
- Lead sponsor
- Eva Sevick
- Other
- Eligibility
- Up to 6 Months
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Anemia of Prematurity
- Interventions
- Red blood cell transfusion
- Procedure
- Lead sponsor
- McMaster University
- Other
- Eligibility
- Up to 48 Hours
- Enrollment
- 424 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2005
- U.S. locations
- 2
- States / cities
- Albany, New York • Brooklyn, New York
- Conditions
- Hydrocephalus in Infants
- Interventions
- Non-Invasive Pressure Monitor
- Device
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 0 Months to 12 Months
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Indianapolis, Indiana
- Conditions
- Hydrocephalus
- Interventions
- ETV/CPC
- Procedure
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 1 Day to 180 Days
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- University Park, Pennsylvania
- Conditions
- Hemorrhage, Premature Infants, Newborn, Hydrocephalus
- Interventions
- ETV/CPC
- Procedure
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 0 Months to 12 Months
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2026
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts
- Conditions
- Hydrocephalus
- Interventions
- Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV+CPC), Ventriculoperitoneal Shunt
- Procedure · Device
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 1 Day to 104 Weeks
- Enrollment
- 176 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 15 more
- Conditions
- Intraventricular Hemorrhage, Hydrocephalus
- Interventions
- Removal of CSF through ventricular access device, Removal of CSF through a ventricular access device
- Procedure
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- Up to 34 Weeks
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- St Louis, Missouri